Pages that link to "Q30372024"
Jump to navigation
Jump to search
The following pages link to Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. (Q30372024):
Displaying 50 items.
- Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung (Q26825031) (← links)
- Current advancements and potential strategies in the development of MERS-CoV vaccines (Q27012578) (← links)
- Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection (Q28744570) (← links)
- Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice (Q28748950) (← links)
- A consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus (Q30148715) (← links)
- Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity (Q30357830) (← links)
- Universal influenza vaccines, a dream to be realized soon. (Q30361950) (← links)
- Influenza vaccines based on virus-like particles (Q30376236) (← links)
- Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge (Q30376482) (← links)
- Progress in developing virus-like particle influenza vaccines. (Q30386640) (← links)
- Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity (Q30392895) (← links)
- Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults (Q30395173) (← links)
- Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses. (Q30398228) (← links)
- Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy (Q30418285) (← links)
- Virus-like particles as universal influenza vaccines (Q30421558) (← links)
- Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists (Q33721641) (← links)
- Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant (Q34576055) (← links)
- The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon (Q34778787) (← links)
- Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs (Q35140889) (← links)
- Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis (Q35272921) (← links)
- Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. (Q35277985) (← links)
- Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis (Q35300720) (← links)
- An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin (Q35749381) (← links)
- Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs (Q35824686) (← links)
- Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses (Q35883016) (← links)
- Intralymphatic treatment of flagellin-ovalbumin mixture reduced allergic inflammation in murine model of allergic rhinitis. (Q35890390) (← links)
- Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface (Q35892435) (← links)
- Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS. (Q36018410) (← links)
- Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand (Q36154739) (← links)
- The Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens (Q36385245) (← links)
- Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant (Q36546276) (← links)
- Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus. (Q36846046) (← links)
- Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses (Q37018558) (← links)
- Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice (Q37101184) (← links)
- Flagellin as an adjuvant: cellular mechanisms and potential. (Q37130379) (← links)
- Influenza virus-like particle vaccines (Q37434529) (← links)
- Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge (Q37455326) (← links)
- Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines (Q37627859) (← links)
- Virus-like particles in vaccine development. (Q37798008) (← links)
- Developments in virus-like particle-based vaccines for infectious diseases and cancer (Q37951525) (← links)
- Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development (Q38059059) (← links)
- Recombinant influenza vaccines. (Q38076422) (← links)
- Developments in virus-like particle-based vaccines for HIV. (Q38081965) (← links)
- VLPs and particle strategies for cancer vaccines (Q38152475) (← links)
- Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use (Q38227184) (← links)
- Advances and challenges in the development and production of effective plant-based influenza vaccines (Q38285425) (← links)
- Antigen delivery by virus-like particles for immunotherapeutic vaccination. (Q38285854) (← links)
- New Approaches for Immunization and Therapy against Human Metapneumovirus (Q38524373) (← links)
- Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses (Q38613574) (← links)
- Bacterial flagellin-a potent immunomodulatory agent. (Q38634734) (← links)